To investigate the relationship between the Uric Acid to HDL Cholesterol Ratio (UHR) and all-cause as well as cardiovascular mortality in patients with gout.
Key Findings:
Higher UHR is associated with increased risk of all-cause and cardiovascular mortality in gout patients, with statistical significance values included. UHR serves as a more effective predictor of mortality compared to UA or HDL-c alone.
Interpretation:
The findings suggest that UHR could be a valuable biomarker for assessing mortality risk in gout patients, highlighting the importance of monitoring uric acid and HDL-c levels. Elaborate on the implications of UHR as a biomarker.
Limitations:
Study relies on self-reported gout diagnosis, which may introduce bias. Specify the potential impact of this bias on results. Potential confounding factors not accounted for in the analysis.
Conclusion:
UHR is a promising composite biomarker that may help in predicting mortality outcomes in gout patients, warranting further research to validate its clinical utility. Emphasize the need for future research more explicitly.
